Key Dates

    ESMO 2017 Congress

    Sep
    8

    September 8-12
    Madrid, Spain

     

    ESMO 2017 Congress ( European Society for Medical Oncology )

    Noxopharm Abstract accepted: " Chemo-sensitisation of Carboplatin by NOX66 Pharmacokinetics and Safety"

    Clinical data to be presented concerns the NOX66-Carboplatin study currently underway in Georgia.